GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
53.73 30.82 30.04 45.39

+8 more quarters

P/S ratio
1.24 0.85 1.21 1.83
P/FCF ratio
7.42 6.91 10.29 13.98
P/Operating CF
12.09 56.38 29.36 19.30
P/B ratio
1.51 1.07 1.57 2.44
Price to Tangible BV
6.14 5.12 7.92 12.62
EV/Sales
1.49 1.17 1.50 2.10
EV/EBITDA
7.06 5.54 6.83 10.14
EV/Operating CF
5.79 5.40 7.10 9.36
EV/FCF
8.87 9.52 12.70 16.03
Quick Ratio
0.41 0.55 2.02 2.62
Current Ratio
1.38 1.47 2.61 3.11
Net Debt/EBITDA
4.11 6.94 4.89 5.91
Debt/Assets
20.77% 24.11% 34.78% 36.90%
Debt/Equity
0.75 0.78 0.79 0.81
Asset Turnover
0.43 0.48 0.57 0.60
Operating CF/Net income
9.47 10.13 6.06 67.94
Capex/Depreciation
(0.63) (0.97) (0.67) (0.82)
Interest Coverage
2.41 1.43 2.18 1.35
Research and Development Expense of Revenue
13.33% 15.55% 14.86% 15.82%
Selling, General and Administrative Expense of Revenue
53.29% 55.60% 52.65% 58.94%
Intangible Assets out of Total Assets
0.21 0.24 0.35 0.37
Share Based Compensation of Revenue
8.28% 8.51% 9.20% 9.24%
Graham Net Nets
(0.10) (0.20) (0.15) (0.11)
Graham Number
1.52 1.62 1.87 1.91
Earnings Yield
1.86% 3.24% 3.33% 2.20%
Free Cash Flow Yield
13.48% 14.46% 9.72% 7.15%
Revenue per Share
0.59 0.57 0.55 0.57
Operating CF per Share
0.24 0.03 0.09 0.22
Capex per Share
(0.04) (0.06) (0.04) (0.05)
Free Cash Flow per Share
0.20 (0.03) 0.05 0.17
Cash per Share
0.87 0.69 0.73 0.79
Shareholders Equity per Share
1.91 1.83 1.73 1.73
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.91 1.83 1.73 1.73
Free Cash Flow
66.42 (9.81) 17.06 58.02
Working Capital
441.46 407.27 397.10 383.66
Capital Expenditures
(14.41) (21.64) (15.83) (18.00)
Net Current Asset Value
(96.00) (132.80) (144.69) (159.28)
EV/EBIT
15.58 11.77 13.63 20.27
Capex to Sales
0.07 0.11 0.08 0.09
Price to Operating Income
13.04 8.54 11.04 17.68
Other line items
Average Receivables
185.58 196.42 190.84 167.27
Average Payables
17.16 14.89 16.77 20.56
Average Assets
1,830.82 1,658.26 1,396.06 1,340.18
Average Common Equity
645.32 638.17 670.46 648.57

Fold the line items

Columns are period end dates